For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
The mission of my research program is to address basic and clinical questions at the intersection of cancer metabolism, mitochondrial genetics, and cancer genomics, with a focus on translational applications in kidney cancer. Our research focuses on developing cutting-edge informatic and modeling approaches to address a single overarching question: how genotype and the tumor microenvironment cooperatively shape metabolic phenotypes.
Gorelick AN, Kim M, Chatila WK, La K, Hakimi AA, Berger MF, Taylor BS, Gammage PA, Reznik E. Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nat Metab. 2021 Apr;3(4):558-570. doi: 10.1038/s42255-021-00378-8. Epub 2021 Apr 8. PMID: 33833465.
Reznik E*†, Christodoulou D*, Goldford JE, Briars E, Sauer U, Segrè D, Noor E. Genome-scale architecture of small molecule regulatory networks and the fundamental tradeoff between regulation and enzymatic activity. Cell Rep. 2017;20(11): 2666–2667. PMCID: PMC5600504
Hakimi AA*, Reznik E*, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell. 2016;29(1):104–116. PMCID: PMC4809063.